Apriem Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Apriem Advisors’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-475	Closed	-$1K	–	674
2015 Q2	$1K	Hold	475	–	–	﹤0.01%	619
2015 Q1	$1K	Hold	475	–	–	﹤0.01%	554
2014 Q4	$1K	Hold	475	–	–	﹤0.01%	515
2014 Q3	$1K	Hold	475	–	–	﹤0.01%	519
2014 Q2	$1K	Hold	475	–	–	﹤0.01%	476
2014 Q1	$1K	Hold	475	–	–	﹤0.01%	488
2013 Q4	$2K	Hold	475	–	–	﹤0.01%	477
2013 Q3	$1K	Hold	475	–	–	﹤0.01%	495
2013 Q2	$1K	Buy	+475	New	+$1K	﹤0.01%	464

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Apriem Advisors's RXII Position: Q3 2015 in Review

Apriem Advisors sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2015, closing a stake of 475 shares — an estimated $1K sold.

Apriem Advisors first reported a position in RXII in Q2 2013 and held it in 9 quarters. The position peaked at $2K in Q4 2013. 78 funds tracked by Wall St. Rank hold RXII as of Q3 2015.

Apriem Advisors reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2015 after selling out during the quarter.
Apriem Advisors sold 475 GALENA BIOPHARMA INC COM shares in Q3 2015, an estimated $1K.
Apriem Advisors first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 9 quarters.
Apriem Advisors's GALENA BIOPHARMA INC COM position peaked at $2K in Q4 2013.
78 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2015.

Based on Apriem Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.